MedPath

Frailty Status and Increased Risk for Falls

Recruiting
Conditions
Frailty
Fall
Anticholinergic Toxicity
Registration Number
NCT04233541
Lead Sponsor
Saglik Bilimleri Universitesi
Brief Summary

We hypothesized that the use of anticholinergic medications may precipitate falls differently by frailty status in older adults. Community-dwelling older subjects admitted to the Geriatrics Outpatient Clinic prospectively enter into the study. Frailty status is defined according to the Physical Frailty Phenotype. The drugs are categorized according to the ACB scale

Detailed Description

Previous studies have found that the use of drugs with anticholinergic properties relate to increased prevalence of falls in older women and men. Frailty is associated with serious health outcomes including falls, hip fractures, and death. Frailty can be a relevant target to investigate its association with the risk of falls among the users of drugs with anticholinergic properties. A recent evidence suggests that the interaction between being frail and adverse outcomes in older adults receiving polypharmacy or centrally acting drugs is complex and not straightforward across all frailty phenotypes.

We classify the participants frail if they met at least three of five criteria, while those having one or two criteria were pre-frail, and others were non-frail. We determine the anticholinergic burden by using the Anticholinergic Cognitive Burden (ACB) Scale developed by Boustani et al.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Community-dwelling older adults
Exclusion Criteria
  • a history of dementia,
  • current delirium or psychotic symptoms,
  • taking antipsychotic medications,
  • being functionally dependent to others,
  • difficulty in communicating with the interviewer,
  • terminal illness,
  • being bedridden or wheelchair bound (≥2 weeks),
  • difficulty in standing or walking,
  • incomplete data

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fall assessment1-2 hours

We will assess the association between anticholinergic burden (ACB) and falls based on frailty status among older adults.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Gulhane Faculty of Medicine & Gulhane Training and Research Hospital

🇹🇷

Ankara, Turkey

Gulhane Faculty of Medicine & Gulhane Training and Research Hospital
🇹🇷Ankara, Turkey
Mehmet I Naharci, Assoc.Prof.
Contact
905445120147
drnaharci@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.